Anthology Diagnostics offers local state-of-the-art genomic profiling analyzing both DNA and RNA.

Our Precision Diagnostics offering utilizes the most advanced technology and software with deep learning to deliver advances in disease detection, prognosis and therapy recommendations. Our high-quality testing requires less tissue, provides faster results and is more cost efficient and affordable. 

Anthology Diagnostics molecular profile tests are well validated and covered by Medicare and most major insurances.

Both solid tumors (lung, colon, breast, etc) and hematologic malignancies (leukemia, multiple myeloma, etc) have molecular profiling tests available. All major types of cancer have molecular testing that can be performed on them but the sample requirements will be different.

Anthology Diagnostics is part of the Genomic Testing Cooperative network of laboratories.

GTC in collaboration with Anthology Diagnostics allows laboratories, health systems and Oncology groups to join this network, share resources, share knowledge, and collaborate in a community environment.

The GTC model produces big data for AI analysis creating value for hospitals, research, drug development, and others involved in cancer care.